India levodopa market is expected to grow at a formidable rate during the forecast period. The India Levodopa market is driven by advancement in diagnosis of Parkinson’s disease progression. Moreover, development of novel formulations for levodopa is further expected to boost the demand through FY2026. Continuous demand of Levodopa to treat Parkinson’s disease is further predicted to increase the product demand in the forthcoming years, thereby bolstering the market growth.

The India levodopa market is segmented based on drug type, composition, source, form, distribution channel, application, end user, company, and region. In terms of composition the market is fragmented into single and combinational. The combinational drug composition dominated the market until 2017 and is forecasted to maintain its dominance during the forecast period as well which can be attributed to certain advantages such as increased compliance, synergy and high efficacy. In addition to this, combination drug therapies offer additive benefits that target multiple pathologic processes, which further contributes to the segmental growth.

The major players operating in the India levodopa market are Wockhardt Ltd., Teva Pharmaceuticals Industries Ltd., Torrent Pharmaceuticals Ltd., Divis Laboratories Ltd., Taj Pharmaceuticals Ltd., Cipla Ltd., Zydus Cadila Healthcare Ltd. (Neuro), GlaxoSmithKline Pharmaceuticals Ltd., Nicholas Piramal India Ltd., Micro Labs Ltd. (Synchro) and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, new product developments and pharma licensing in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India Levodopa market from FY2016 to FY2019.
  • To estimate and forecast the market size of India levodopa market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India levodopa market based on drug type, composition, source, form, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India levodopa market.
  • To identify drivers and challenges for India levodopa market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India Levodopa market.
  • To identify and analyze the profile of leading players operating in India levodopa market.
  • To identify key sustainable strategies adopted by market players in India levodopa market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India levodopa market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Levodopa manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers.
  • Organizations, forums and alliances related to levodopa.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India levodopa market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Levodopa Market, By Drug Type:
    • Rytary
    • Duopa
    • Sinemet
    • Caramet
    • Others
  • India Levodopa Market, By Composition:
    • Single
    • Combinational
  • India Levodopa Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Levodopa Market, By Form:
    • Tablet
    • Capsule
    • Others
  • India Levodopa Market, By Distribution Channel:
    • Online
    • Offline
  • India Levodopa Market, By Application:
    • Parkinson’s Disease
    • Dopamine Responsive Dystonia
    • Restless Legs Syndrome (RLS)
    • Others
  • India Levodopa Market, By End User:
    • Adult
    • Pediatric
  • India Levodopa Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India levodopa market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India levodopa market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Levodopa Market

4.    Executive Summary

5.    Manufacturing Levodopa

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Levodopa

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Levodopa Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Drug Type (Rytary, Duopa, Sinemet, Caramet, Others)

7.2.2.     By Composition (Single, Combinational)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Form (Tablet, Capsule, Others)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Parkinson’s Disease, Dopamine Responsive Dystonia, Restless Legs Syndrome (RLS) and Others)

7.2.7.     By End User (Adult v/s Pediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Wockhardt Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Teva Pharmaceuticals Industries Ltd.

14.1.3.  Torrent Pharmaceuticals Ltd.

14.1.4.  Divis Laboratories Ltd.

14.1.5.  Taj Pharmaceuticals Ltd.

14.1.6.  Cipla Ltd.

14.1.7.  Zydus Cadila Healthcare Ltd. (Neuro)

14.1.8.  GlaxoSmithKline Pharmaceuticals Ltd.

14.1.9.  Nicholas Piramal India Ltd.

14.1.10.                Micro Labs Ltd. (Synchro)

15.  Strategic Recommendations

About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com